Swine Flu Vaccine Debuts

BASEL, Switzerland
Published: June 11, 2009

The first swine flu vaccine has been successfuly created by Swiss pharmaceutical company Novartis AG. The batch was completed a day after the World Health Organization (WHO) declared the H1N1 influenza as a pandemic.

The vaccine was produced weeks ahead of schedule and will still need to undergo pre-clinical evaluation and testing. Drug makers may have vaccines approved and ready for sale after September, according to the Associated Press.

Novartis officials say the company can produce millions of H1N1 vaccines from its Germany-based plant. A second facility is being built in Holly Springs, N.C.

More than 30 governments have requested vaccine supplies, including the U.S. Department of Health and Human Service, which placed a $289 million order in May, according to Novartis officials.

——Article Continues Below——

Get the latest industry news and research delivered directly to your inbox.

Posted in: News

Tagged with:

Strategy & Planning Series
Strategy & Planning Series
Strategy & Planning Series
Strategy & Planning Series
Strategy & Planning Series